- Home
- MNOV vs PMVP Comparison
MNOV vs PMVP Comparison
Compare MNOV & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- PMVP
- Stock Information
- Founded
- MNOV 2000
- PMVP 2013
- Country
- MNOV United States
- PMVP United States
- Employees
- MNOV N/A
- PMVP N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MNOV Health Care
- PMVP Health Care
- Exchange
- MNOV Nasdaq
- PMVP Nasdaq
- Market Cap
- MNOV 65.7M
- PMVP 77.4M
- IPO Year
- MNOV 2005
- PMVP 2020
- Fundamental
- Price
- MNOV $1.22
- PMVP $1.25
- Analyst Decision
- MNOV Strong Buy
- PMVP Strong Buy
- Analyst Count
- MNOV 2
- PMVP 1
- Target Price
- MNOV $7.00
- PMVP $5.00
- AVG Volume (30 Days)
- MNOV 64.9K
- PMVP 2.7M
- Earning Date
- MNOV 11-12-2025
- PMVP 11-06-2025
- Dividend Yield
- MNOV N/A
- PMVP N/A
- EPS Growth
- MNOV N/A
- PMVP N/A
- EPS
- MNOV N/A
- PMVP N/A
- Revenue
- MNOV $134,599.00
- PMVP N/A
- Revenue This Year
- MNOV N/A
- PMVP N/A
- Revenue Next Year
- MNOV N/A
- PMVP N/A
- P/E Ratio
- MNOV N/A
- PMVP N/A
- Revenue Growth
- MNOV N/A
- PMVP N/A
- 52 Week Low
- MNOV $1.13
- PMVP $0.81
- 52 Week High
- MNOV $2.55
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- MNOV 37.71
- PMVP 43.37
- Support Level
- MNOV $1.25
- PMVP $1.12
- Resistance Level
- MNOV $1.38
- PMVP $1.40
- Average True Range (ATR)
- MNOV 0.04
- PMVP 0.16
- MACD
- MNOV -0.01
- PMVP -0.03
- Stochastic Oscillator
- MNOV 0.00
- PMVP 17.94
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.